Archive for August, 2007

Amgen's patents protect Epogen. Again.

Amgen’s got a record of savvy patenting to protect their blockbusters, and they’ve just done it again. A U.S. Federal District Court in Boston has ruled that Roche’s pegylated-erythropoietin infringes one of Amgen’s patents. I’m eager to hear the backstory on this one. Amgen previously prevented Transkaryotic (now owned by Shire) from using a completely […]

Carnival of Biotechnology

Welcome to the second August 2007 edition of Carnival of Biotechnology. International Biotechnology The Times (UK) has a report on the UK biotech sector, calling for consolidation to overcome a lack of capital. The Wall Street Journal has an article on Novartis’ lost patent case in India, where a patent on an improved version of […]

Journal of Commercial Biotechnology

I’ve recently joined the Journal of Commercial Biotechnology as managing editor. Drop me a line if you would like to make a submission. The most recent issue, edited by Neil Henderson, has just been published: Volume 13, Issue 3 Articles When should you fire the founder? PDF William Bains Constructing a processual model of communication […]

Call for chapters: Best practices in biotechnology business development

I’m in the final stages of preparing a book on best practices in biotechnology business development, and am looking for 1-2 more chapters. The chapters I’ve received so far are: Top Five Mistakes Communicating With Investors and The Media Securing Intellectual Property From The Inside Out Aggressive Intellectual Property Strategies Biotechnology Transfers And Models Facilitate […]

Drug Patent Expirations in August 2007

Courtesy of Drug Patent Expirations in August 2007*Drugs may be covered by more than one patent Tradename Applicant Generic Name Patent Number Patent Expiration ACCUPRIL Pfizer Pharms quinapril hydrochloride 4,743,450 AUG 24,2007 ACCURETIC Pfizer Pharms hydrochlorothiazide; quinapril hydrochloride 4,743,450 AUG 24,2007 ANTARA (MICRONIZED) Oscient fenofibrate 4,800,079 AUG 10,2007 CEREBYX Parke Davis fosphenytoin sodium 4,925,860 […]

Carnival of Biotechnology

Welcome to the August 2007 edition of Carnival of Biotechnology. Industry Trends Singapore-based ES Cell International, the company that was poised to lead in stem cell therapeutics, has abandoned its plans for stem cell therapies. Sometimes its hard for a company to live up to the high expectations they engender in their quest for financing. […]